Debernardi-Venon W - Search Results

1

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.

Alessandria C, Ottobrelli A, Debernardi-Venon W, Todros L, Cerenzia MT, Martini S, Balzola F, Morgando A, Rizzetto M, Marzano A. Alessandria C, et al. J Hepatol. 2007 Oct;47(4):499-505. doi: 10.1016/j.jhep.2007.04.010. Epub 2007 May 24. J Hepatol. 2007. PMID: 17560680 Clinical Trial.

2

AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers.

Debernardi-Venon W, Martini S, Biasi F, Vizio B, Termine A, Poli G, Brunello F, Alessandria C, Bonardi R, Saracco G, Rizzetto M, Marzano A. Debernardi-Venon W, et al. J Hepatol. 2007 Jun;46(6):1026-33. doi: 10.1016/j.jhep.2007.01.017. Epub 2007 Feb 9. J Hepatol. 2007. PMID: 17336417 Clinical Trial.

3

Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.

Alessandria C, Debernardi-Venon W, Carello M, Ceretto S, Rizzetto M, Marzano A. Alessandria C, et al. Dig Liver Dis. 2009 Apr;41(4):298-302. doi: 10.1016/j.dld.2008.09.014. Epub 2009 Jan 20. Dig Liver Dis. 2009. PMID: 19158001

4

Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.

Marzano A, Debernardi Venon W, Sacco M, Rizzetto M. Marzano A, et al. Minerva Gastroenterol Dietol. 2015 Sep;61(3):171-2. Minerva Gastroenterol Dietol. 2015. PMID: 26161570 No abstract available.

5

Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension.

Debernardi-Venon W, Barletti C, Alessandria C, Marzano A, Baronio M, Todros L, Saracco G, Repici A, Rizzetto M. Debernardi-Venon W, et al. Dig Dis Sci. 2002 Feb;47(2):401-4. doi: 10.1023/a:1013790610327. Dig Dis Sci. 2002. PMID: 11855558

6

Recurrence of hepatitis B in liver transplants treated with antiviral therapy.

Marzano A, Debernardi-Venon W, Smedile A, Brunetto MR, Torrani Cerenzia MR, Actis GC, Zamboni F, Ghisetti V, Piantino P, David E, Salizzoni M, Rizzetto M. Marzano A, et al. Ital J Gastroenterol Hepatol. 1998 Feb;30(1):77-81. Ital J Gastroenterol Hepatol. 1998. PMID: 9615271

7

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, Gentilcore E, Piantino P, Barbui AM, David E, Negro F, Rizzetto M. Marzano A, et al. J Hepatol. 2001 Jun;34(6):903-10. doi: 10.1016/s0168-8278(01)00080-0. J Hepatol. 2001. PMID: 11451175

8

Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis.

Debernardi Venon W, Elia C, Stradella D, Bruno M, Fadda M, DeAngelis C, Rizzetto M, Saracco G, Marzano A. Debernardi Venon W, et al. Eur J Intern Med. 2014 Sep;25(7):674-9. doi: 10.1016/j.ejim.2014.06.013. Epub 2014 Jul 10. Eur J Intern Med. 2014. PMID: 25018142 Free article. Clinical Trial.

9

Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment.

Marzano A, Debernardi-Venon W, Condreay L, Rizzetto M. Marzano A, et al. Transplantation. 1998 Jun 15;65(11):1499-500. doi: 10.1097/00007890-199806150-00017. Transplantation. 1998. PMID: 9645811

10

Hypercalcaemia secondary to hepatocellular carcinoma.

Leone N, Debernardi-Venon W, Marzano A, Massari M, Rizzetto M. Leone N, et al. Ital J Gastroenterol Hepatol. 1999 Oct;31(7):604-6. Ital J Gastroenterol Hepatol. 1999. PMID: 10604102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters